News
04-23-2010, 11:50 AM
The experts say complicated government oversight, inadequate funding, and inefficient management interfere with the National Cancer Institute's ability to design and complete clinical trials on new drugs and other therapies.
More... (http://www.healthcentral.com/breast-cancer/news-515778-98.html)
More... (http://www.healthcentral.com/breast-cancer/news-515778-98.html)